S. 5059 · 119th Congress · Health
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
What it does
The Congressional Research Service hasn’t published a summary of this bill yet. Summaries usually follow within a few weeks of introduction.
Roll call votes
No recorded roll call votes on this bill. Most bills never get one; many pass by voice vote or unanimous consent, or stay in committee.
Latest action
Jul 21, 2026 · Read twice and referred to the Committee on Health, Education, Labor, and Pensions.